Homocysteine and oxidative stress in Egyptian children with Down syndrome

Clinical Biochemistry

Volumn 43, Issue 12, 2010, Pages 963-967

  Meguid, Nagwa A ^a   Dardir, Ahmed A ^a   El Sayed, Eman M ^a   Ahmed, Hanaa H ^a   Hashish, Adel F ^a   Ezzat, Afaf ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Copper; Down syndrome; Folic acid; Homocysteine; Oxidative stress; Vitamins E and C; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COBALT 57; COPPER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; IODINE 125; ZINC; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TOCOPHEROL;

ADULT; AMINO ACID METABOLISM; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DOWN SYNDROME; EGYPT; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL; BLOOD; FEMALE; MALE; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD;

ADULT; ASCORBIC ACID; CHILD; CHILD, PRESCHOOL; COPPER; DOWN SYNDROME; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOCOPHEROLS; ZINC;

EID: 77954314882     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.04.058     Document Type: Article

References (54)

1. Hernandez D., Fisher E.M.C. Down syndrome genetics: unravelling a multifactorial disorder. Hum Mol Genet 1996, 5:1411-1416.
2. Hassold T., Sherman S. Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin Genet 2000, 57:95-100.
3. Fenech M. Recommended dietary allowances (RDAS) for genomic stability. Mutat Res 2002, 480-481:51-54.
4. Eskes T.K.A.B. Abnormal folate metabolism in mothers with Down syndrome offspring. Eur J Obstet Gynecol Reprod Biol 2006, 124:130-133.
5. Botto L.D., Yang Q. 5, 10-Methylene-tetrahydrofolate reductase gene variants and congenital anomalies: a huge review. Am J Epidemiol 2000, 151:862-877.
6. Das U.N. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia and Alzheimer's disease. But how and why?. Prostaglandins Leukot Essent Fatty Acids 2008, 78(1):11-19.
7. Brattström L., Landgren F., Israelsson B., et al. Lowering blood homocysteine with folic acid based supplements: meta analysis of randomized trials. BMJ 1998, 316:894-898.
8. Arbuzova S. Why it is necessary to study the role of mitochondrial genome in trisomy 21 pathogenesis?. Down Syndr Res Pract 1998, 5:26-29.
9. Booksbank B.W., Balazs R. Superoxide dismutase; glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res 1984, 318:37-44.
10. Le Pecheur M., Bourdon E., Play E., et al. Oxidized SD-1 alters proteasome activities in vitro and in the cortex of SOD-1 overxprossing mice. FEBS Lett 2005, 579:3613-3618.
11. Buonocore G. Early oxidative stress in amoniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007, 40(3-4):177-180.
12. Bambrick L.L., Fiskum G. Mitochondrial dysfunction in mouse trisomy 16 brain. Brain Res 2008, 1188:9-16.
13. 12 in plasma and blood samples. Clin Chim Acta 1979, 95:147-149.
14. Frantzen F., Faaren A.L., Alfheim I., Nordhei A.K. An enzyme conversion immunoassay for determining total Hcy in plasma or serum. Clin Chem 1998, 44:311-316.
15. Desia ID Machlin L.J. Vitamin E. Awiely Interscience Publication 1988, 255. John Wiely & Sons, New York. 4th Ed. J. Augustin, B.P. Klein, D. Beker, P.B. Venugopal (Eds.).
16. Jagota S.K., Dani H.M. A new colorimetric technique for the estimation of vitamin C using folic phenol reagent. Anal Biochem 1982, 127:178-182.
17. Satoh K. serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978, 90:37-48.
18. Abe A., Yamashita S., Noma A. Sensitive direct colorimetric assay for copper in serum. Clin Chem 1989, 552:35.
19. Homsher R., Zak B. Spectrophotometric investigation of sensitivity complexing agents for the determination of zinc in serum. Clin Chem 1985, 31:1310-1313.
20. Freeman S., Grantham M., Hassold T. Cytogenetic and molecular studies of spontaneous human abortions. Am J Hum Genet 1996, 49:916.
21. Kohli U., Arora S., Kabra M., RamaKrishnan L., Gulati S., Pandey R.M. Prevalence of MTHFR C677T polymorphism in North Indian mothers having babies with trisomy 21 Down syndrome. Downs Syndr Res Pract 2008, 12(2):133-137.
22. Coppede F. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 2009, 682(1):54-70.
23. Bosco P., Guéant-Rodriguez R.M., Anello G., et al. Methionine synthase (MTR) 2756 polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR)66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003, 121(3):219-224.
24. Takamura N., Kondoh T., Ohgi S., et al. Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr 2004, 43(5):285-287.
25. Meguid N.A., Dardir A.A., Khass M., Hossieny L.E., Ezzat A., El-Awady M.K. MTHFR genetic polymorphism as a risk factor in Egyptian mothers with Down syndrome children. Dis-Markers 2008, 24(1):19-26.
26. Bosco P., Gueant-Rodriguez R.M., Anello G., et al. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A Sep 1 2003, 121A(3):219-224.
27. Biselli J.M., Goloni-Bertollo E.M., Zampiere B.L., Haddad R., Eberlin M.N., Pavarino-Bertelli E.C. Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: maternal risk factors for Down syndrome in Brazil. Genet Mol Res 2008, 7(1):33-42.
28. Scala I., Granese B., Sellitto M., et al. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Am J Med Genet A 2007, 143(9):1018-1019.
29. Coppede F., Migheli F., Bargagna S., et al. Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring. Neurosci Lett 2009, 449(1):15-19.
30. Wainfain E., Poirier L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992, 52.
31. Balaghi M., Wagner C. DNA methylation in folate deficiency-use of CPG methylase. Biochem Biophys Res Commun 1993, 139:1184-1190.
32. Al-Gazali L.I., Padmanabhan R., Melnyk S., et al. Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am J Med Genet 2001, 103(2):128-132.
33. Chango A., Mircher C., James S.J., Rethore M.O., Nicolas J.P. One carbon metabolism and trisomy 21: analysis of the genetic polymorphism. Ann Biol Clin 2002, 60(6):647-653.
34. Licastro F., Marocchi A., Penco S., et al. Does Down's syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Arch Gerontol Geriatr 2006, 43:381-387.
35. Vagra P., Olah V.A., Olah E. Biochemical alterations in patients with DS. Orv Heril 2008, 149(26):1203-1213.
36. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P., James S.J. Homocysteine metabolism in children with Down syndrome in vitro modulation. Am J Hum Genet 2001, 69(1):88-95.
37. Coppus A.W., Fekkes D., Verhoeven W.M., Tuinier S., Egger J.I., vn Duijn C.M. Plasma amino acids and neopterin in healthy persons with Down's syndrome. J Neural Transm 2007, 114(8):1041-1045.
38. Betteridge D.J. What is oxidative stress?. Metabolism 2000, 49(2):3-8.
39. Perrone S., Longini M., Bellieni C.V., et al. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007, 40:177-180.
40. Dennery P.A. Role of redox in fetal development and neonatal seases. Antioxid Redox Signal 2004, 6:147-153.
41. Boldyrev A.A., Carpenter D.D., Huentelman M.J., Peters C.M., Johnson P. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells. Biochem Biophys Res Commun 1999, 256:320-324.
42. Palleschi S., De Angelis S., Rossi B., et al. Homocysteinemia correlates with plasma thiol redox status in patients with end stage renal disease. Nephron Clin Pract 2008, 108(2):106-112.
43. Sibrian-vazquez M., Escobedo J.O., Lim S., Samoei G.K., Strongin R.M. Homocystamides promote free radical and oxidative damage to proteins. Proc Natl Acad Sci USA 2010, 107(2):551-554.
44. Edirimanne V.E., Woo C.W., Siow Y.L., Pierce G.N., Xie J. Homocysteine stimulates NADPH oxidase mediated superoxide anion production leading to endothelial dysfunction in rats. Can J Physiol Pharmcol 2007, 85(12):1236-1247.
45. Martin I., Gibert M.J., Pintos C., Noguera A., Besalduch A., Obrador A. Oxidative stress in mothers who have conceived fetus with neural tube defects: the role of aminothiols and selenium. Clin Nutr 2004, 23:507-514.
46. Fuzukawa K., Takese S., Tsukatani H. The effect of concentration on the antioxidant effectiveness of α-tocopherol in lipid induced by superoxide free radicals. Arch Biochem 1989, 240:117-120.
47. Barkai G., Arbuzova S., Berkenstadt M., Heifetz S., Cuckle H. Frequency in Down's syndrome and neural tube defects in the same family. Lancet 2003, 361:1331-1335.
48. Verhaar M.C., Stroes E., Rabelink T.J. Folate and cardiovascular disease. Arterioscler Thromb Vas Biol 2002, 22:6-13.
49. Heffner J.E., Repine J.E. Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989, 140:531.
50. Gualandri W., Gualandri L., Demartini G., et al. Redox balance in patients with Down's syndrome before and after supplementation with alpha-lipoic acid and l-cysteine. Int J Clin Pharmacol Res 2003, 23(1):23-30.
51. Garcez M.E., Peres W., Salvador M. Oxidative stress and hematologic and biochemical parameters with Down syndrome. Mayo Clin Proc 2005, 80:1607-1611.
52. Jovanovic S.V., Clements D., Macleod K. Biomarker of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998, 25(9):1044-1048.
53. de Hann J.B., Susil B., Pritchard M., Kola I. An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis. J Neural Transm Suppl 2003, 67:67-83.
54. Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975, 44:147-159.